Epigenome-based cancer risk prediction: rationale, opportunities and challenges
Martin Widschwendter(University College Hospital), Nora Pashayan(University College London), Yvonne Vergouwe(Leiden University), Joakim Dillner(Malmö University), Bartha Maria Knoppers(McGill University), Yann Joly(McGill University), Line Bjørge(Haukeland University Hospital), Frank Dudbridge(University of Cambridge), Nadia Harbeck(Breast Center), Odette Wegwarth(Max Planck Institute for Human Development), Gaby Sroczynski(UMIT - Private Universität für Gesundheitswissenschaften, Medizinische Informatik und Technik), Felix G. Rebitschek(Max Planck Institute for Human Development), Andrew E. Teschendorff(Computational Physics (United States)), Allison Jones(University College London), Anne-Marie Tassé(McGill University and Génome Québec Innovation Centre), Iona Evans(University College London), Ineke Bolt, Michal Zikán(Charles University), David Cibula(Prague University of Economics and Business), Ewout W. Steyerberg(Erasmus MC), Daniel Reisel(University College London), Nicoletta Colombo(University of Milan), Karin Sundström(Karolinska University Hospital), Inez D. de Beaufort, Uwe Siebert(Harvard University)
Cited by 173
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.2k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Internal validation of predictive models
|Journal of Clinical Epidemiology|2001|2.6k